Maria Laura Sargentini‐Maier
Maria Laura Sargentini‐Maier publishes mostly in Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Biomedical Engineering, on topics such as Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies and Innovative Microfluidic and Catalytic Techniques Innovation.
- World rank
- #2,502,560 of 7,710,434 ranked researchers
- Rank in Belgium
- #22,774 of 67,186
- Works
- 32
- Citations
- 997
- Citations per work
- 31.2
What does Maria Laura Sargentini‐Maier research?
Maria Laura Sargentini‐Maier's work is mostly in Medicine (39%), Engineering (9%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1339.2%
- Medicine1339.2%
- Everything else1339.2%
- Life Sciences412.7%
- Physical Sciences38.9%
- Engineering38.9%
- 1Psychiatry and Mental health18% of their works
- 2Pediatrics, Perinatology and Child Health15% of their works
- 3Biomedical Engineering9% of their works
- 4Immunology8% of their works
- 5Hematology6% of their works
- 6Molecular Biology5% of their works
Research topics
- Epilepsy research and treatment
- Pharmacological Effects and Toxicity Studies
- Innovative Microfluidic and Catalytic Techniques Innovation
- Complement system in diseases
- Neuroscience and Neuropharmacology Research
- Drug Transport and Resistance Mechanisms
- Monoclonal and Polyclonal Antibodies Research
- Anesthesia and Sedative Agents
Which keywords describe Maria Laura Sargentini‐Maier's research?
The keywords of their largest research topics: Antiepileptic Drugs, Genetics, Epilepsy, Seizures, Prenatal Exposure, Teratogenicity, Droplet Formation and Microfluidics.
- Sedation
- Therapeutic Antibodies
- Neurotransmission
- Fc Receptors
- Immune
- Microfluidics
- Teratogenicity
- Seizures
- Genetics
- Antiepileptic Drugs
- Epilepsy
- Prenatal Exposure
- Droplet Formation
- Complement
- ATP-dependent Transporters
- Multidrug Resistance
- Synaptic Plasticity
- Anesthesia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Antiepileptic Drugs252 topics
- Genetics192 topics
- Epilepsy141 topic
- Seizures141 topic
- Prenatal Exposure111 topic
- Teratogenicity111 topic
- Droplet Formation71 topic
- Microfluidics71 topic
- Complement51 topic
- Immune51 topic
- ATP-dependent Transporters41 topic
- Fc Receptors41 topic
- Multidrug Resistance41 topic
- Neurotransmission41 topic
- Synaptic Plasticity41 topic
- Therapeutic Antibodies41 topic
- Anesthesia31 topic
- Sedation31 topic
Where does Maria Laura Sargentini‐Maier work?
Maria Laura Sargentini‐Maier's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Maria Laura Sargentini‐Maier have?
OpenAlex counts 32 works and 997 citations for Maria Laura Sargentini‐Maier, an h-index of 15, ranking #2,502,560 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Maria Laura Sargentini‐Maier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.